Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Gavras

Showing results (141-150 of 166) with videos related to

Pageof 17
Sort By:
Journal of Clinical Hypertension|December 1, 1987
Double-blind, placebo-controlled trial of twice-daily nifedipine as a step-2 agent in mild essential hypertensionL P Svetkey, M H Weinberger, H Gavras, et al.
Journal of Human Hypertension|January 10, 2014
Differential gene expression of bradykinin receptors 1 and 2 in peripheral monocytes from patients with essential hypertensionM E Marketou, J Kontaraki, E Zacharis, et al.
Circulation Research|February 1, 1975
Malignant hypertension resulting from deoxycorticosterone acetate and salt excess: role of renin and sodium in vascular changesH Gavras, H R Brunner, J H Laragh, et al.
Clinical Science (London, England : 1979)|December 1, 1981
Effects of the oral angiotensin-converting enzyme inhibitor MK-421 in human hypertensionH Gavras, J Biollaz, B Waeber, et al.
British Journal of Clinical Pharmacology|January 1, 1979
Orally active angiotensin-converting enzyme inhibitor (SO 14,225) as a treatment for essential hypertensionH R Brunner, H Gavras, B Waeber, et al.
The American Journal of Cardiology|September 20, 1973
Volume factor in low and normal renin essential hypertension. Treatment with either spironolactone or chlorthalidoneE D Vaughan, J H Laragh, I Gavras, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|October 9, 1998
Chronic sympathetic suppression in the treatment of chronic congestive heart failureA J Manolis, C Olympios, M Sifaki, et al.
Annals of Internal Medicine|January 1, 1979
Converting enzyme inhibition in hypertensive emergenciesC P Tifft, H Gavras, G R Kershaw, et al.
Hypertension (Dallas, Tex. : 1979)|July 1, 1981
Role of reactive hyperreninemia in blood pressure changes induced by sodium depletion in patients with refractory hypertensionH Gavras, B Waeber, G R Kershaw, et al.
Stroke|February 5, 2000
Genetic predisposition to stroke in relatives of hypertensivesM Nicolaou, A L DeStefano, I Gavras, et al.
Pageof 17

Showing results (141-150 of 166) with videos related to

Sort By:
Pageof 17
Journal of Clinical Hypertension|December 1, 1987
Double-blind, placebo-controlled trial of twice-daily nifedipine as a step-2 agent in mild essential hypertensionL P Svetkey, M H Weinberger, H Gavras, et al.
Journal of Human Hypertension|January 10, 2014
Differential gene expression of bradykinin receptors 1 and 2 in peripheral monocytes from patients with essential hypertensionM E Marketou, J Kontaraki, E Zacharis, et al.
Circulation Research|February 1, 1975
Malignant hypertension resulting from deoxycorticosterone acetate and salt excess: role of renin and sodium in vascular changesH Gavras, H R Brunner, J H Laragh, et al.
Clinical Science (London, England : 1979)|December 1, 1981
Effects of the oral angiotensin-converting enzyme inhibitor MK-421 in human hypertensionH Gavras, J Biollaz, B Waeber, et al.
British Journal of Clinical Pharmacology|January 1, 1979
Orally active angiotensin-converting enzyme inhibitor (SO 14,225) as a treatment for essential hypertensionH R Brunner, H Gavras, B Waeber, et al.
The American Journal of Cardiology|September 20, 1973
Volume factor in low and normal renin essential hypertension. Treatment with either spironolactone or chlorthalidoneE D Vaughan, J H Laragh, I Gavras, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|October 9, 1998
Chronic sympathetic suppression in the treatment of chronic congestive heart failureA J Manolis, C Olympios, M Sifaki, et al.
Annals of Internal Medicine|January 1, 1979
Converting enzyme inhibition in hypertensive emergenciesC P Tifft, H Gavras, G R Kershaw, et al.
Hypertension (Dallas, Tex. : 1979)|July 1, 1981
Role of reactive hyperreninemia in blood pressure changes induced by sodium depletion in patients with refractory hypertensionH Gavras, B Waeber, G R Kershaw, et al.
Stroke|February 5, 2000
Genetic predisposition to stroke in relatives of hypertensivesM Nicolaou, A L DeStefano, I Gavras, et al.
Pageof 17